Healthcare: The Week in Healthcare

GSK brings in agency

- GlaxoSmithKline has awarded the UK PR contract for its asthma treatment to Fleishman-Hillard. The agency has been brought on board following a competitive pitch to handle comms support for Seretide, GSK's asthma and Chronic Obstructive Pulmonary Disease treatment.

- Vascular Noninvasive Screening & Diagnostic Centre has appointed Euro RSCG Biss Lancaster, expanding the agency's healthcare portfolio. It is charged with promoting the centre's heart disease prevention service.

- Abraxis Bioscience, the biotech firm, has appointed College Hill's life sciences team to support the European launch of its metastatic breast cancer treatment Abraxane. College Hill's remit includes corporate and product-based PR. It will be headed up by life sciences managing partner Sue Charles.

- Baxter has turned to healthcare shop Ashley Communications to handle its haemophilia franchise. The agency will specifically work on its Advate and FEIBA products. It will expand Baxter's European medical education programme, working with key opinion leaders across Europe.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Would you like to post a comment?

Please Sign in or register.